Literature DB >> 2055645

Physiology of the prostate.

J Frick1, W Aulitzky.   

Abstract

The presence of the prostate is universal in mammals; when compared among species the prostate is marked by variations in its anatomy, biochemistry and pathology. The epithelial cells provide secretions that empty through ducts into the urethra to form a major component of the seminal plasma of the ejaculate. The prostate is stimulated to grow and is maintained in size and function by the presence of serum testosterone. Several protein-type growth factors, such as urogastrone and prostatropin, may also affect prostatic growth. After testosterone from the plasma has entered the prostatic cell through diffusion it is metabolized to other steroids by a series of enzymes. Over 95% of testosterone is converted to the most important prostatic androgen dihydrotestosterone. DHT then binds to the activated androgen receptor. The hormone receptor complex undergoes transformation and translocation into the nucleus. In the nucleus RNA-polymerase is activated followed by the synthesis of mRNA. The noncellular stroma and connective tissue compose the extracellular matrix. The extracellular matrix plays an important role in development and control of cellular functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055645     DOI: 10.1007/bf01643679

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  PITUITARY FACTORS INFLUENCING GROWTH OF THE PROSTATE.

Authors:  J T GRAYHACK
Journal:  Natl Cancer Inst Monogr       Date:  1963-10

2.  Enzymic histochemistry of human prostate. Localization of oxidative enzymes, esterase, and aminopeptidase in the normal and hyperplastic human prostate.

Authors:  M NIEMI; M HARKONEN; T K LARMI
Journal:  Arch Pathol       Date:  1963-05

3.  Studies on prostaglandin; occurrence, formation and biological actions.

Authors:  R ELIASSON
Journal:  Acta Physiol Scand Suppl       Date:  1959

4.  The prostatic antibacterial factor: identity and significance.

Authors:  W R Fair; N Wehner
Journal:  Prog Clin Biol Res       Date:  1976

5.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

6.  Analysis of the zinc-binding protein derived from the human benign hypertrophic prostate.

Authors:  J G Heathcote; R J Washington
Journal:  J Endocrinol       Date:  1973-09       Impact factor: 4.286

7.  The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture.

Authors:  I Lasnitzki; H R Franklin
Journal:  J Endocrinol       Date:  1972-08       Impact factor: 4.286

8.  The relationship of cellular structure and function: the matrix system.

Authors:  J T Isaacs; E R Barrack; W B Isaacs; D S Coffey
Journal:  Prog Clin Biol Res       Date:  1981

9.  Purification of a human prostate specific antigen.

Authors:  M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Invest Urol       Date:  1979-09

10.  Prostatic osteoblastic factor.

Authors:  S C Jacobs; D Pikna; R K Lawson
Journal:  Invest Urol       Date:  1979-11
View more
  8 in total

Review 1.  Antiretroviral drug concentrations in semen of HIV-1 infected men.

Authors:  S Taylor; A S Pereira
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

Review 2.  An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine.

Authors:  Shabir Ahmad Bhat; Shameem Ahmad Rather; Naquibul Islam
Journal:  Asian J Urol       Date:  2021-05-29

Review 3.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy.

Authors:  Shea P Connell; Robert Mills; Hardev Pandha; Richard Morgan; Colin S Cooper; Jeremy Clark; Daniel S Brewer
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

5.  Antichlamydial antibodies and citric acid in patients with chronic prostatitis.

Authors:  Iwona Ostaszewska-Puchalska; Bozena Zdrodowska-Stefanow; Jerzy Badyda; Zofia Galewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

Review 6.  Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.

Authors:  Nelson T Peterson; Chad M Vezina
Journal:  Toxics       Date:  2022-02-16

7.  A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data.

Authors:  Shea P O'Connell; Maria Frantzi; Agnieszka Latosinska; Martyn Webb; William Mullen; Martin Pejchinovski; Mark Salji; Harald Mischak; Colin S Cooper; Jeremy Clark; Daniel S Brewer
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

8.  The evaluation of markers of prostatic inflammation and function of the prostate gland in patients with chronic prostatitis.

Authors:  Bozena Zdrodowska-Stefanow; Iwona Ostaszewska-Puchalska; Jerzy Badyda; Zofia Galewska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-07-29       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.